Top Markets
Coin of the day
Zynex, Inc. Zynex, Inc.

Zynex, Inc.

ZYXI
주식 순위 #35519
Zynex, Inc., operating through its subsidiaries, specializes in the... Zynex, Inc., operating through its subsidiaries, specializes in the development, production, and sale of medical devices. These devices primarily utilize electrical stimulation to alleviate both chronic and acute pain, and to stimulate and exercise muscles for rehabilitation. The company's core product offerings include NexWave, a versatile, dual-channel device combining interferential current, transcutaneous electrical nerve stimulation (TENS), and neuromuscular electrical stimulation (NMES), which is actively marketed to physicians and therapists by its field sales force. Other significant products are NeuroMove, an electrical stimulator activated by electromyography; InWave, specifically designed for treating female urinary incontinence; and E-Wave, another type of NMES device. Zynex also provides private-label accessories, such as electrodes for conducting electrical currents to the body and batteries for powering electrotherapy products. Beyond its own manufactured goods, the company acts as a distributor for several third-party medical items. These include Comfortrac/Saunders for cervical traction, JetStream for therapeutic hot/cold applications, LSO Back Braces for lumbar support, and various knee braces. Expanding its technological portfolio, Zynex offers advanced monitoring solutions. This includes the Zynex Fluid Monitoring System (CM-1500), a non-invasive device that tracks relative fluid volume changes in surgical and recovery settings to identify fluid loss during operations or internal bleeding afterward. A wireless version, the CM-1600, provides similar non-invasive fluid volume monitoring for adult patients. Additionally, the company supplies the NiCO CO-Oximeter and the HemeOx tHb Oximeter, both non-invasive, laser-based devices for co-oximetry and total hemoglobin pulse oximetry, respectively. Zynex's diverse product range is utilized across various medical applications, including pain management, rehabilitation for stroke and spinal cord injuries, hemodynamic monitoring, and pulse oximetry. The company distributes its products primarily through its direct sales force, mainly within the United States. Established in 1996, Zynex, Inc. is based in Englewood, Colorado.
주가
$0.125
마지막 동기화: 2026-04-02
시가총액
$3.80M
변동 (1일)
56.25%
변동 (1년)
-91.78%
국가
US
거래 Zynex, Inc. (ZYXI)

카테고리

Zynex, Inc. (ZYXI)의 영업이익률
2026 기준 영업이익률 TTM: 0.00%
Zynex, Inc.의 최신 재무 보고서와 주가에 따르면 현재 영업이익률 (TTM)은 0.00%입니다. 2026년 말 기준 영업이익률은 0.00%였습니다.
Zynex, Inc.의 영업이익률 기록 (2026 ~ 2026)
매년 말 영업이익률
연도 영업이익률 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 영업이익률
회사 영업이익률 영업이익률 차이 국가
1.62% -
US
0.00% -
US
1.03% -
US
0.00% -
US
-0.21% -
AU
회사의 영업이익률이란?
영업이익률은 회사의 수익성을 평가하는 핵심 지표입니다. 높은 영업이익률은 일반적으로 긍정적으로 간주되며, 이는 회사가 제품이나 서비스를 생산 비용보다 훨씬 높은 가격에 판매할 수 있음을 보여줍니다. 영업이익률은 회사의 수익을 매출로 나누어 계산합니다.